Skip to main content
OpenTrials
Completed

NCT Number: NCT03493243

Teenagers After London Terrorist Attack

* Context: Since March 2012, several terrorist attacks have been perpetrated in France (Toulouse, Montauban, Paris, Nice ...). In March 2017, 53 french teenagers were victims in a terrorist attack in London (Westminster Bridge). * Main goal = to estimate the psycho-traumatic impact and to describe cares and management of high school students, victims of the terrorist attack in London on 2017, March the 22nd. * 3 secondary objectives: 1) Clinical (occurrence of Post Traumatic Stress Disorders or other disorders); 2) Epidemiological (risk factors for developing disorders, avoiding care); 3) Preventive and therapeutic.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–20 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU, Brest, France

Loading trial locations.

About this study

Inclusion criterion: 53 teenagers of Saint-Joseph high school (Concarneau, France) directly exposed to the terrorist attack.

Methodology: self questionnaires and heterogenous questionnaires; descriptive statistics (means +/- standard deviations; search for a significant difference according to traumatic symptomatology)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 53 teenagers, from Concarneau (France) high school, directly exposed from London terrorist attack (22.03.2017).

Exclusion criteria

  • All persons not directly exposed;
  • Relatives of teenagers;
  • 3 physically injured teenagers.

Treatment and study plan

questionnaires

Other

2-hour clinical observation

Primary outcomes

  1. PTSD

    Time frame: One year after the terrorist attack (Day 1)

    Post Traumatic Stress Disorder (Self-Questionnaire :Posttraumatic stress disorder checklist 5 )

Secondary outcomes

  1. Clinical (occurence of Post Traumatic Stress Disorders or other disorders)

    Time frame: One year after the terrorist attack (Day 1)

    Mini International Neuro-psychiatric Interview for children and adolescent

  2. Epidemiological (risk factors for developing disorders, avoiding care);

    Time frame: One year after the terrorist attack (Day 1)

    LEC = Life Event checklist

  3. Preventive and therapeutic

    Time frame: One year after the terrorist attack (Day 1)

    MINI = Mini International Neuropsychiatric Interview

  4. Epidemiological (risk factors for developing disorders, avoiding care);

    Time frame: One year after the terrorist attack (Day 1)

    ALCES = Adolescent Life Change Event Scale

  5. Epidemiological (risk factors for developing disorders, avoiding care);

    Time frame: One year after the terrorist attack (Day 1)

    EPS 10 = "Echelle de Provisions Sociales Abrégées";

  6. Epidemiological (risk factors for developing disorders, avoiding care);

    Time frame: One year after the terrorist attack (Day 1)

    Whodas 2.0 = World Health Organization Disability Assessment Schedule

  7. Preventive and therapeutic

    Time frame: One year after the terrorist attack (Day 1)

    Questionnaire about use of psychoactive substances

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

AVAL Cohort Study First Step, Observational Study, After One Year

Acronym: AVAL

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Apr 10, 2018
Registry last updated
Oct 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.